Friday, June 26, 2015 1:14:55 PM
In our case, I lost money on ENTB when the "buyout" of a vet practice, one in many that was to occur in order to apply ENTB's potential development of animal stem cell treatments ended rather badly as I recall with a lawsuit and Koos having to turn the practice back over to original entity.
After that, nothing concrete was ever brought forward as I recall. In fact, I was surprised when C. Ichim was brought to ENTB late last year, but maybe this was some type of "trial period" where she could do animal testing and Koos could evaluate her work for what ended up being her hiring by RGBP.
We can only guess at the somewhat strange scenario of multiple companies and spinoffs, but to my knowledge, the only real value and action currently is in RGBP. Does ENTB or Zander even own any IP?
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM